Phase 3 COPD Trial, Recruiting

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People who have been diagnosed with chronic obstructive pulmonary disease (COPD) for at least 12 months, based on recognised international guidelines.
• People whose lung function test results show a specific level of airflow limitation — moderate to moderately severe (confirm specific numbers with trial site).
• People who have been on a stable combination of three standard COPD medications (a long-acting beta-agonist, a long-acting muscarinic antagonist, and an inhaled corticosteroid) for at least 6 months, with no dose changes in the last 3 months.
• People who have had at least 2 COPD flare-ups (episodes where symptoms significantly worsen) in the past 12 months.

Who may not be able to join:

• People who have a significant lung condition other than COPD.
• People who need continuous oxygen therapy at a high flow rate (above 4 litres per minute through a nasal tube or equivalent).
• People whose blood oxygen levels are too low at rest — specifically, a resting oxygen saturation below 88% while breathing normal air or at their usual oxygen level.
• People who have a clinically significant heart condition, including severe heart failure, certain types of reduced heart function, or lung-related heart strain (confirm details with trial site).

Important: Always verify eligibility with the trial site directly before applying.